Showing results (61-70 of 207) with videos related to
Sort By:
Pageof 21
Molecular Oncology|June 15, 2017
New insights into the role of EMT in tumor immune escapeStéphane Terry, Pierre Savagner, Sandra Ortiz-Cuaran, et al.Blood|June 25, 2008
Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cellsEmmanuelle Fourmentraux-Neves, Abdelali Jalil, Sylvie Da Rocha, et al.Molecular Immunology|May 16, 2002
Role of p53 in the sensitization of tumor cells to apoptotic cell deathJérôme Thiery, Hamid Echchakir, Guillaume Dorothée, et al.Frontiers in Immunology|October 7, 2015
Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic StressMeriem Hasmim, Yosra Messai, Linda Ziani, et al.Cancer Letters|July 27, 2020
Hypoxia-driven intratumor heterogeneity and immune evasionStéphane Terry, Agnete S T Engelsen, Stéphanie Buart, et al.International Journal of Cancer|February 13, 2004
Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patientsAsma Gati, Sylvie Da Rocha, Nadia Guerra, et al.Autophagy|May 3, 2013
EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy inductionIntissar Akalay, Bassam Janji, Meriem Hasmim, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
p53 potentiation of tumor cell susceptibility to CTL involves Fas and mitochondrial pathwaysJérôme Thiery, Soraya Abouzahr, Guillaume Dorothee, et al.The Journal of Experimental Medicine|April 30, 2014
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activationMuhammad Zaeem Noman, Giacomo Desantis, Bassam Janji, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicityGuillaume Dorothée, Isabelle Vergnon, Jeanne Menez, et al.Pageof 21